BioVenture VoiCes with Chris Garabedian Episode 23: a16z's Vineeta Agarwala
Jul 28, 2025
Vineeta Agarwala, a physician-scientist and general partner at a16z who previously worked at GV, Flatiron Health, and the Broad Institute. She recounts her path from biophysics and MD-PhD training to building clinical-genomic data products. Conversations cover a16z’s founder-first investing approach, platform vs product trade-offs, the Lilly partnership, and how biotech and AI-driven consumer health are converging.
AI Snips
Chapters
Transcript
Episode notes
Learn Corporate Finance To Translate Science
- Learn business-side skills early to understand how science gets funded and scaled; corporate finance and consulting taught Vineeta valuation and transaction thinking.
- These skills helped her translate scientific projects into fundable commercial strategies later in VC.
MD-PhD And Broad Postdoc Gave Genomics Front Row Seat
- Vineeta did an MD-PhD at Harvard/MIT and a Broad postdoc with David Altshuler focused on human genetics and sequencing platforms.
- The Broad's team-based genomics work taught sequencing platform comparison, variant calling, and translational collaboration with pharma.
Flatiron Paired Genomics With Real World Outcomes
- At GV Vineeta focused on clinical and genomic data translation and joined Flatiron to pair tumor sequencing with longitudinal clinical outcomes.
- Flatiron purchased a large community EHR and partnered with pharma to create differentiated real-world oncology datasets.